ADCM 4919/25 - Various Medications

The tender ADCM 4919/25 pertains to the procurement of various medications required for healthcare services. This tender is part of a broader initiative to ensure the availability of essential pharmaceuticals in the public health sector. The medications listed under this tender include a range of products, identified by their respective codes: 1686825, 1687225, 1687025, 1686925, 1687325, 1686625, 1687425, and 1687125. Each code corresponds to specific medication types that are critical for patient care. Interested suppliers are expected to meet stringent quality standards and regulatory requirements to ensure that the medications provided are safe and effective for use. The procurement process will be conducted in accordance with established public procurement regulations, emphasizing transparency and fairness. Suppliers must prepare their bids carefully, ensuring compliance with all specified requirements and deadlines. This tender represents an important opportunity for pharmaceutical companies to contribute to public health initiatives by supplying necessary medications. The location for the delivery of these medications will be specified in the tender documents, and potential bidders are encouraged to review all details thoroughly to ensure a successful application.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 17.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.